REFERENCES
- Sharma SM, Nestel AR, Lee RWJ, et al. Clinical review: anti-TNF alpha therapies in uveitis: perspective on 5 years of clinical experience. Ocul Immunol Inflamm. 2009: 17(6): 403–414.
- Bongartz T.Tocilizumab for rheumatoid and juvenile idiopathic arthritis. Lancet. 2008: 371(9617):961–963.
- Vallochi AL, Commodaro AG, Schwartzman JP, et al. The role of cytokines in the regulation of ocular autoimmune inflammation. Cytokine Growth Factor Rev. 2007:18(1–2): 135–141.
- Yoshimura T, Sonoda KH, Ohguro N, et al. Involvement of Th17 cells and the effect of anti IL-6 therapy in autoimmune uveitis Rheumatology (Oxford). 2009:48(4);347–354.
- Hohki S, Ohguru N, Haruta H, et al. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Res. 2010:91(2):162–170.